.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Chubb
QuintilesIMS
Argus Health
Cantor Fitzgerald
Cipla
US Army
Medtronic
Express Scripts

Generated: December 12, 2017

DrugPatentWatch Database Preview

OPTIMARK IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Optimark In Plastic Container, and what generic alternatives are available?

Optimark In Plastic Container is a drug marketed by Liebel-flarsheim and is included in one NDA.

The generic ingredient in OPTIMARK IN PLASTIC CONTAINER is gadoversetamide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the gadoversetamide profile page.

Summary for OPTIMARK IN PLASTIC CONTAINER

Drug patent expirations by year for OPTIMARK IN PLASTIC CONTAINER

Pharmacology for OPTIMARK IN PLASTIC CONTAINER

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheimOPTIMARK IN PLASTIC CONTAINERgadoversetamideINJECTABLE;INJECTION020976-002Dec 8, 1999RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIMARK IN PLASTIC CONTAINERgadoversetamideINJECTABLE;INJECTION020976-001Dec 8, 1999RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIMARK IN PLASTIC CONTAINERgadoversetamideINJECTABLE;INJECTION020976-003Dec 8, 1999RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIMARK IN PLASTIC CONTAINERgadoversetamideINJECTABLE;INJECTION020976-004Dec 8, 1999RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: OPTIMARK IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Liebel-flarsheimOPTIMARK IN PLASTIC CONTAINERgadoversetamideINJECTABLE;INJECTION020976-001Dec 8, 1999► Subscribe► Subscribe
Liebel-flarsheimOPTIMARK IN PLASTIC CONTAINERgadoversetamideINJECTABLE;INJECTION020976-001Dec 8, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Covington
Novartis
AstraZeneca
Merck
Queensland Health
QuintilesIMS
Johnson and Johnson
Baxter
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot